Transgene Biotek Q3 Results

  • BSE: 526139
  • NSE: -
  • ISIN: INE773D01018
  • Sector: Biotechnology & Drugs
BSE
6.520.03 (0.46%)
Volume16.55 K
Updated: Tue 26 Nov, 2024 | 15:29:24
NSE
This stock is not traded on NSE
Today: 6.51
6.81
52-Wk: 5.79
12.46

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Transgene Biotek Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ CompDec 22YoY Comp
    Total Revenue 0.040.04-%0.00-%
    Selling/ General/ Admin Expenses Total 0.080.08-%0.08-%
    Depreciation/ Amortization 0.020.02-%1.24-%
    Other Operating Expenses Total 0.080.09-%0.06-%
    Total Operating Expense 0.180.19-%1.38-%
    Operating Income -0.13-0.14-%-1.38-%
    Net Income Before Taxes -0.12-0.13-%-1.38-%
    Net Income -0.12-0.13-%-1.38-%
    Diluted Normalized EPS -0.02-0.02-%-0.18-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts